Shimadzu Establishes Latin American Subsidiary | GenomeWeb

NEW YORK (GenomeWeb News) – Shimadzu today announced the creation of a wholly owned subsidiary in Uruguay to bolster its Central and South American business.

Shimadzu Latin America (SLA) will serve as Shimadzu's base in the region. Shimadzu do Brasil Comercio (SBL) in Sao Paulo was created in 1997 and had been coordinating Shimadzu's operations in Central and South America. As SBL's business within Brazil grew and Brazilian regulations limited SBL's trading activities with its neighbors, Shimadzu chose to create SLA, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.